Identifiers
Database identifiers and provenance.
- Ligand ID
CQE- PDB
4cqe- UniProt (similar protein)
P15056- Target protein
- P10721
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 104.3
- −1 ≤ LogP ≤ 5 6.39
- MW ≤ 500 Da 627.7
- LogP ≤ 5 6.39
- H-bond donors ≤ 5 2
- H-bond acceptors ≤ 10 7
- Rotatable bonds ≤ 10 8
- TPSA ≤ 140 Ų 104.3
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
CC(=O)Nc1cc(ccn1)c2c(nc(s2)C3CCN(CC3)C4CC4)c5cccc(c5F)NS(=O)(=O)c6cc(ccc6F)FCC(=O)Nc1cc(ccn1)c2c(nc(s2)C3CCN(CC3)C4CC4)c5cccc(c5F)NS(=O)(=O)c6cc(ccc6F)F
InChI=1S/C30H28F3N5O3S2/c1-17(39)35-26-15-19(9-12-34-26)29-28(36-30(42-29)18-10-13-38(14-11-18)21-6-7-21)22-3-2-4-24(27(22)33)37-43(40,41)25-16-20(31)5-8-23(25)32/h2-5,8-9,12,15-16,18,21,37H,6-7,10-11,13-14H2,1H3,(H,34,35,39)InChI=1S/C30H28F3N5O3S2/c1-17(39)35-26-15-19(9-12-34-26)29-28(36-30(42-29)18-10-13-38(14-11-18)21-6-7-21)22-3-2-4-24(27(22)33)37-43(40,41)25-16-20(31)5-8-23(25)32/h2-5,8-9,12,15-16,18,21,37H,6-7,10-11,13-14H2,1H3,(H,34,35,39)
WXOCHOSJBRDQIZ-UHFFFAOYSA-NWXOCHOSJBRDQIZ-UHFFFAOYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ domain
- Source
- PDB
- Binding sites
- PF07714
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand CQE →
- PDB RCSB structure 4cqe →
- UniProt UniProt P15056 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “CQE”) →
Other ligands for this protein
Quick navigation to other ligands bound to P10721.
PDB 232
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 100
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).